Literature DB >> 23311417

The impact of hepatic steatosis on liver regeneration after partial hepatectomy.

Petra G Kele1, Eric J van der Jagt, Annette S H Gouw, Ton Lisman, Robert J Porte, Marieke T de Boer.   

Abstract

BACKGROUND & AIM: Experimental studies in animals have suggested that liver regeneration is impaired in steatotic livers. However, few studies have focused on the impact of steatosis in patients undergoing partial hepatectomy (PH). This study aims to determine the role of steatosis on liver regeneration in humans following PH.
METHODS: Eighty-eight patients undergoing PH were included in this study. All patients underwent CT-scanning of the liver preoperatively and 7 days after surgery. Additional CT-scans were performed 6 months post-operatively. Preoperative and post-operative volumes of the total liver (TLV), future liver remnant (FLR) and liver remnant (LR) were measured on CT-scans. Regeneration indices (RI) were calculated at 7 days and 6 months using the formula: (Volume LR-Volume FLR)/Volume FLR × 100%. Based on histological examination of the resected part of the liver, patients were classified into three groups: (1) no steatosis, (2) mild steatosis (1-29%) and (3) moderate-to-severe steatosis (≥30%).
RESULTS: The early RI (at day 7) was 40%, 24% and 20% for patients in group 1, 2 and 3 respectively. Late RI (at 6 months) was 81% for group 1, 44% for group 2 and 22% for group 3 (P = 0.019). At 7 days, the LR represented 79%, 80% and 79% of the TLV for groups 1-3. At 6 months, this was 93%, 92% and 79% respectively.
CONCLUSION: Although early RI after PH did not differ in patients with or without steatosis, the late RI in patients with moderate-to-severe steatosis was lower, suggesting that late liver regeneration is impaired in these patients.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23311417     DOI: 10.1111/liv.12089

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  13 in total

1.  Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis.

Authors:  Kristopher P Croome; Roberto Hernandez-Alejandro; Maile Parker; Julie Heimbach; Charles Rosen; David M Nagorney
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

2.  What if Prometheus had steatosis? Potential use of FGF19 to promote regeneration of the fatty liver.

Authors:  Philip M Brown; Yaron Rotman
Journal:  Gut       Date:  2017-03-08       Impact factor: 23.059

Review 3.  Fibroblast growth factors 19 and 21 in acute liver damage.

Authors:  Zhao Shan; Gloria Alvarez-Sola; Iker Uriarte; María Arechederra; Maite G Fernández-Barrena; Carmen Berasain; Cynthia Ju; Matías A Avila
Journal:  Ann Transl Med       Date:  2018-06

4.  Lack of Multidrug Resistance-associated Protein 4 Prolongs Partial Hepatectomy-induced Hepatic Steatosis.

Authors:  Ajay C Donepudi; Gregory J Smith; Oladimeji Aladelokun; Yoojin Lee; Steven J Toro; Marisa Pfohl; Angela L Slitt; Li Wang; Ji-Young Lee; John D Schuetz; José E Manautou
Journal:  Toxicol Sci       Date:  2020-06-01       Impact factor: 4.849

5.  Therapeutic targets for liver regeneration after acute severe injury: a preclinical overview.

Authors:  Hidenobu Kojima; Kojiro Nakamura; Jerzy W Kupiec-Weglinski
Journal:  Expert Opin Ther Targets       Date:  2020-01-10       Impact factor: 6.902

6.  Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor.

Authors:  Tanaporn Khamphaya; Natsasi Chukijrungroat; Vitoon Saengsirisuwan; Kisha A Mitchell-Richards; Marie E Robert; Albert Mennone; Meenakshisundaram Ananthanarayanan; Michael H Nathanson; Jittima Weerachayaphorn
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

7.  Biochemical Parameters for Longitudinal Monitoring of Liver Function in Rat Models of Partial Hepatectomy Following Liver Injury.

Authors:  Nele Boeykens; Peter Ponsaerts; Dirk Ysebaert; Kathleen De Greef
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy.

Authors:  Fernando Ezquer; Javiera Bahamonde; Ya-Lin Huang; Marcelo Ezquer
Journal:  Stem Cell Res Ther       Date:  2017-01-28       Impact factor: 6.832

9.  Injury-dependent retention of intraportally administered mesenchymal stromal cells following partial hepatectomy of steatotic liver does not lead to improved liver recovery.

Authors:  Nele Boeykens; Peter Ponsaerts; Annemie Van der Linden; Zwi Berneman; Dirk Ysebaert; Kathleen De Greef
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

10.  Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice.

Authors:  Golnar Karimian; Marc Kirschbaum; Zwanida J Veldhuis; Fernanda Bomfati; Robert J Porte; Ton Lisman
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.